secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOADAPTIVES, INC. (BDPT)
CIK:        0001575142
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0001640334-23-000587
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAdaptives appoints Dr. Yaguang Liu to board and increases authorized shares to 1.25 billion
--------------------------------------------------------------------------------

- Dr. Yaguang Liu appointed to board effective April 5, 2023; holds 32 US patents on natural botanicals.
- Authorized common stock increased from 750M to 1.25B shares; preferred shares authorized at 10M.
- Amendment approved by board and majority shareholders on March 6, 2023, effective March 27, 2023.
- Dr. Liu is founder of L.Y. Research Corp and has experience with FDA IND applications and clinical studies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1575142/000164033423000587/0001640334-23-000587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1575142/000164033423000587/bdpt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-23-000587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer